Evonetix
Evonetix is a biotech company in Cambridge, United Kingdom, founded in 2015. It has raised $66.3M across 3 rounds, most recently a $24.0M Extension Round in February 2023.
- Headquarters
- Cambridge
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- evonetix.com
- Total Funding
- $66.3M
- Last Round
- $24.0M Extension RoundFeb 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Cambridge-based company developing a desktop DNA synthesis platform using a radically different approach to gene synthesis.
Summary
It lists 51–200 employees. It has raised $66.3M in total across 3 rounds, most recently a $24.0M Extension Round in Feb 2023. Investors include Foresite Capital, Molten Ventures and DCVC (Data Collab).
Funding History
Feb 2023
Sign up to see all 3 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/evonetix"><img src="https://indexed.vc/api/badge/company/evonetix" alt="Evonetix on Indexed.vc" width="260" height="76" /></a>